Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements Of Cash Flows

v3.25.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (3,496,432) $ 1,202,651
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 627,315 801,792
Share based compensation 30,815 197,306
Credit loss provision (25,079) 38,501
Fair value remeasurement of earnout consideration   (350,000)
Fair value remeasurement of warrant liability   (3,728,593)
Fair value remeasurement of contingent forward contract (109,492)  
Fair value remeasurement of contingent value rights (19,179) (376,085)
Loss on extinguishment of debt 343,471  
Gain on sale of assets   (6,118)
Interest and accretion expense 571,241 764,870
Changes in assets and liabilities:    
Trade accounts receivable 978,228 14,894
Inventories 195,091 641,301
Income taxes 14,615 6,162
Other assets, net 12,186 (184,227)
Accounts payable (941,847) (684,194)
Accrued compensation and benefits 20,770 (48,386)
Customer deposits (443,775) (293,877)
Other accrued liabilities (62,478) (191,396)
Accrued interest (1,098,799) (453,881)
Net cash used in operating activities (3,403,349) (2,649,280)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures   (5,594)
Proceeds from the sale of property, plant and equipment   6,118
Net cash provided by investing activities   524
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments against loans payable (9,401,939) (372,299)
Payments related to equity issuance costs (1,568,099) (81,012)
Proceeds from the issuance of common stock and pre-funded warrants under registered direct offering 9,473,398 1,000,000
Proceeds from the issuance of common stock on the exercise of pre-funded warrants 11,078  
Proceeds from the issuance of contingent forward contract 5,515,525  
Proceeds from the issuance of common stock under at-the-market offering 351,372  
Proceeds from issuance of common stock, net of shares withheld   1,040
Payment of contingent consideration related to acquisition (389,104)  
Purchase of common stock   (2,865)
Net cash provided by financing activities 3,992,231 544,864
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 588,882 (2,103,892)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 1,151,348 5,396,343
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 1,740,230 3,292,451
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Interest paid 1,077,033 416,504
SUPPLEMENTAL DISCLOSURES OF NON-CASH ACTIVITIES:    
Loss on extinguishment of debt (343,471)  
Issuance of common stock for settlement of loss contingencies $ 880,756  
Deemed dividend on Convertible Preferred Stock and PIPE Warrants   11,322,639
Conversion of redeemable convertible preferred stock to common stock   $ 8,386,387